This list is based on the watchlists of people on Stock Events who follow SPHRF. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Starpharma Holdings Limited is a biopharmaceutical enterprise focused on the research, development, and global commercialization of dendrimer-based products for the pharmaceutical, life sciences, and other industries. Its current offerings include VivaGel, a non-antibiotic treatment and preventative measure for bacterial vaginosis. The company also provides the antiviral VivaGel condom and VIRALEZE, an antiviral nasal spray. Furthermore, Starpharma is actively progressing its DEP (dendrimer drug delivery) technology platform. This platform supports multiple oncology candidates in clinical development, such as DEP docetaxel (Phase 2), DEP cabazitaxel (Phase 2), DEP gemcitabine (Phase 1/2), and DEP irinotecan (Phase 2), all aimed at treating cancer. The DEP technology is also being applied to radiotheranostics for cancer diagnosis and therapy, Antibody Drug Conjugates (including DEP HER-2 ADC), and non-oncology programs. Additionally, DEP AZD0466 is currently in Phase 1/2 clinical trials for haematological malignancies. Founded in 1996, the company maintains its headquarters in Abbotsford, Australia.
FAQs
What is Starpharma stock price today?▼
The current price of SPHRF is $0.32 USD — it has decreased by -8.57% in the past 24 hours. Watch Starpharma stock price performance more closely on the chart.
What is Starpharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Starpharma stocks are traded under the ticker SPHRF.
Is Starpharma stock price growing?▼
SPHRF stock has risen by +0% compared to the previous week, the month change is a -44.83% fall, over the last year Starpharma has showed a +52.38% increase.
What is Starpharma market cap?▼
Today Starpharma has the market capitalization of 134.7M
When is the next Starpharma earnings date?▼
Starpharma is going to release the next earnings report on March 2, 2027.
What is Starpharma revenue for the last year?▼
Starpharma revenue for the last year amounts to 8.07M USD.
What is Starpharma net income for the last year?▼
SPHRF net income for the last year is -5.2M USD.
Does Starpharma pay dividends?▼
Yes, SPHRF dividends are paid annual. The last dividend per share was 0.02 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Starpharma have?▼
As of November 19, 2026, the company has 50 employees.
In which sector is Starpharma located?▼
Starpharma operates in the Health & Wellness sector.
When did Starpharma complete a stock split?▼
Starpharma has not had any recent stock splits.
Where is Starpharma headquartered?▼
Starpharma is headquartered in Richmond, Australia.